RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Molecular Data Stock

Molecular Data Net Income 2024

Molecular Data Net Income

-328 M CNY

Ticker

MKD

ISIN

US60852L1061

WKN

A2PYCA

In 2024, Molecular Data's profit amounted to -328 M CNY, a 69.47% increase from the -193.55 M CNY profit recorded in the previous year.

The Molecular Data Net Income history

YEARNET INCOME (undefined CNY)
2020-
2019-
2018-
2017-
2016-

Molecular Data Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Molecular Data, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Molecular Data from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Molecular Data’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Molecular Data. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Molecular Data’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Molecular Data’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Molecular Data’s growth potential.

Molecular Data Revenue, EBIT and net profit per share

DateMolecular Data RevenueMolecular Data EBITMolecular Data Net Income
20207.6 B CNY-331.56 M CNY-328 M CNY
201913.21 B CNY-192.21 M CNY-193.55 M CNY
20189.05 B CNY-235.79 M CNY-254.64 M CNY
20174.2 B CNY-89.73 M CNY-107.81 M CNY
20163.21 B CNY-105.77 M CNY-113.94 M CNY

Molecular Data stock margins

The Molecular Data margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Molecular Data. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Molecular Data.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Molecular Data's sales revenue. A higher gross margin percentage indicates that the Molecular Data retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Molecular Data's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Molecular Data's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Molecular Data's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Molecular Data. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Molecular Data's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Molecular Data Margin History

Molecular Data Gross marginMolecular Data Profit marginMolecular Data EBIT marginMolecular Data Profit margin
2020-0.13 %-4.36 %-4.32 %
20190.76 %-1.46 %-1.47 %
20180.89 %-2.6 %-2.81 %
20171.2 %-2.14 %-2.57 %
20160.81 %-3.3 %-3.55 %

Molecular Data Aktienanalyse

What does Molecular Data do?

Molecular Data Inc. is a leading technology company specializing in the use of big data, artificial intelligence (AI), and blockchain technology in the chemical and pharmaceutical industry. The company was founded in 2014 and is headquartered in Shanghai, China. Molecular Data Inc. has a comprehensive database consisting of millions of chemical compounds, which aids chemists, pharmaceutical companies, and researchers in identifying, exploring, and developing new drugs. The company places great importance on integrating data and technologies to accelerate and improve drug development. Molecular Data Inc. provides cloud-based solutions based on the analysis of big data through AI algorithms and blockchain technology. It offers platforms, as well as consulting and training services, to support customers in efficiently utilizing the platforms. The company's main products include the MDL platform, which enables the integration of data, knowledge, and algorithms to accelerate drug development processes. The MDL platform is a cloud-based system that provides access to a database of millions of compounds and allows users to receive real-time results. Molecular Data Inc. also offers a blockchain-based platform for the chemical and pharmaceutical industry, enhancing the transparency and security of data and information. The platform facilitates secure data exchange between different companies and regulatory authorities, providing improved control and monitoring of data. Another important service provided by Molecular Data Inc. is consulting and training for companies in implementing big data, AI, and blockchain into their workflows. The company aims to equip its customers with the necessary skills and knowledge to optimize their business processes and increase competitiveness. Molecular Data Inc. is divided into several divisions to ensure efficient collaboration and product development. These divisions include research and development, sales and marketing, finance and administration, and information technology. The company strives to expand its business through strategic partnerships and acquisitions. It has already completed several acquisitions to strengthen its expertise in big data, AI, and blockchain. Through these strategic measures, the company has been able to offer its customers a comprehensive range of products and services to enhance performance and increase competitiveness. Overall, Molecular Data Inc. is a significant company in the chemical and pharmaceutical industry that specializes in the integration of data and technologies to enhance process efficiency and speed. The company aims to strengthen its position as a market leader through innovation and strategic partnerships. Molecular Data ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Molecular Data's Profit Margins

The profit margins of Molecular Data represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Molecular Data's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Molecular Data's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Molecular Data's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Molecular Data’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Molecular Data stock

How much profit has Molecular Data made this year?

Molecular Data has made -328 M CNY this year.

How has the profit developed compared to last year?

The profit has increased by 69.47% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Molecular Data publish its earnings?

Molecular Data publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Molecular Data?

The profits of Molecular Data are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Molecular Data?

You can learn more about the earnings of Molecular Data by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Molecular Data pay?

Over the past 12 months, Molecular Data paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Molecular Data is expected to pay a dividend of 0 CNY.

What is the dividend yield of Molecular Data?

The current dividend yield of Molecular Data is .

When does Molecular Data pay dividends?

Molecular Data pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Molecular Data?

Molecular Data paid dividends every year for the past 0 years.

What is the dividend of Molecular Data?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Molecular Data located?

Molecular Data is assigned to the 'Cyclical consumption' sector.

Wann musste ich die Aktien von Molecular Data kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Molecular Data from 8/6/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 8/6/2024.

When did Molecular Data pay the last dividend?

The last dividend was paid out on 8/6/2024.

What was the dividend of Molecular Data in the year 2023?

In the year 2023, Molecular Data distributed 0 CNY as dividends.

In which currency does Molecular Data pay out the dividend?

The dividends of Molecular Data are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Molecular Data

Our stock analysis for Molecular Data Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Molecular Data Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.